title: Multi-synergetic ZnO platform for high performance cancer therapy.
abstract: ZnO platforms were evaluated for designing a high-performance anticancer drug (daunorubicin) carrier. Hollow structured ZnO, compared with nanorods, acts as a multi-purpose entity by serving as smart carriers and exhibiting synergetic photodynamic cytotoxic effects, which are ascribed to their high-specific surface area, hollow interior, pH-responsiveness and inherent photodynamism.
authors.affiliation: Department of BIN Fusion Technology and Polymer BIN Research Center, Chonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju 561-756, Republic of Korea.
authors.forename: Nirmalya
authors.initials: N
authors.lastname: Tripathy
authors.forename: Rafiq
authors.initials: R
authors.lastname: Ahmad
authors.forename: Hyun Ah
authors.initials: HA
authors.lastname: Ko
authors.forename: Gilson
authors.initials: G
authors.lastname: Khang
authors.forename: Yoon-Bong
authors.initials: YB
authors.lastname: Hahn
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003630:Daunorubicin / Q000737:chemistry / Q000627:therapeutic use*; D004337:Drug Carriers / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010316:Particle Size; D016062:Porosity; D013329:Structure-Activity Relationship; D013499:Surface Properties; D015034:Zinc Oxide / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D015034:Zinc Oxide; D003630:Daunorubicin